48 related articles for article (PubMed ID: 11912160)
1. Atypical protein kinase C zeta as a target for chemosensitization of tumor cells.
Filomenko R; Poirson-Bichat F; Billerey C; Belon JP; Garrido C; Solary E; Bettaieb A
Cancer Res; 2002 Mar; 62(6):1815-21. PubMed ID: 11912160
[TBL] [Abstract][Full Text] [Related]
2. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C inhibition and x-linked inhibitor of apoptosis protein degradation contribute to the sensitization effect of luteolin on tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in cancer cells.
Shi RX; Ong CN; Shen HM
Cancer Res; 2005 Sep; 65(17):7815-23. PubMed ID: 16140950
[TBL] [Abstract][Full Text] [Related]
4. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.
Ravi R; Bedi A
Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase.
Cohen EE; Lingen MW; Zhu B; Zhu H; Straza MW; Pierce C; Martin LE; Rosner MR
Cancer Res; 2006 Jun; 66(12):6296-303. PubMed ID: 16778206
[TBL] [Abstract][Full Text] [Related]
6. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
7. c-Myc plays a role in cellular susceptibility to death receptor-mediated and chemotherapy-induced apoptosis in human monocytic leukemia U937 cells.
Dong J; Naito M; Tsuruo T
Oncogene; 1997 Aug; 15(6):639-47. PubMed ID: 9264404
[TBL] [Abstract][Full Text] [Related]
8. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-kappaB.
Schmelz K; Wieder T; Tamm I; Müller A; Essmann F; Geilen CC; Schulze-Osthoff K; Dörken B; Daniel PT
Oncogene; 2004 Sep; 23(40):6743-59. PubMed ID: 15273737
[TBL] [Abstract][Full Text] [Related]
11. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta.
Ghosh PM; Bedolla R; Mikhailova M; Kreisberg JI
Cancer Res; 2002 May; 62(9):2630-6. PubMed ID: 11980660
[TBL] [Abstract][Full Text] [Related]
12. p27Kip1 induces drug resistance by preventing apoptosis upstream of cytochrome c release and procaspase-3 activation in leukemic cells.
Eymin B; Haugg M; Droin N; Sordet O; Dimanche-Boitrel MT; Solary E
Oncogene; 1999 Feb; 18(7):1411-8. PubMed ID: 10050878
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C-zeta mediates retinal degeneration in response to TNF.
Liang H; Baudouin C; Behar-Cohen F; Crisanti P; Omri B
J Neuroimmunol; 2007 Feb; 183(1-2):104-10. PubMed ID: 17207538
[TBL] [Abstract][Full Text] [Related]
14. A role for PKCzeta in potentiation of the topoisomerase II activity and etoposide cytotoxicity by wortmannin.
Reis C; Giocanti N; Hennequin C; Mégnin-Chanet F; Fernet M; Filomenko R; Bettaieb A; Solary E; Favaudon V
Mol Cancer Ther; 2005 Oct; 4(10):1457-64. PubMed ID: 16227394
[TBL] [Abstract][Full Text] [Related]
15. Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer.
Nazarenko I; Jenny M; Keil J; Gieseler C; Weisshaupt K; Sehouli J; Legewie S; Herbst L; Weichert W; Darb-Esfahani S; Dietel M; Schäfer R; Ueberall F; Sers C
Mol Cancer Res; 2010 Jun; 8(6):919-34. PubMed ID: 20501645
[TBL] [Abstract][Full Text] [Related]
16. The selective inhibition of nuclear PKCζ restores the effectiveness of chemotherapeutic agents in chemoresistant cells.
Rimessi A; Zecchini E; Siviero R; Giorgi C; Leo S; Rizzuto R; Pinton P
Cell Cycle; 2012 Mar; 11(5):1040-8. PubMed ID: 22333579
[TBL] [Abstract][Full Text] [Related]
17. Role-shifting PKCζ fosters its own proapoptotic destruction by complexing with Bcl10 at the nuclear envelope of human cervical carcinoma cells: a proteomic and biochemical study.
Chiarini A; Marconi M; Pacchiana R; Dal Prà I; Wu J; Armato U
J Proteome Res; 2012 Aug; 11(8):3996-4012. PubMed ID: 22812606
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation.
Bezombes C; de Thonel A; Apostolou A; Louat T; Jaffrézou JP; Laurent G; Quillet-Mary A
Mol Pharmacol; 2002 Dec; 62(6):1446-55. PubMed ID: 12435813
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase Czeta abrogates the proapoptotic function of Bax through phosphorylation.
Xin M; Gao F; May WS; Flagg T; Deng X
J Biol Chem; 2007 Jul; 282(29):21268-77. PubMed ID: 17525161
[TBL] [Abstract][Full Text] [Related]
20. Bcl10 crucially nucleates the pro-apoptotic complexes comprising PDK1, PKCζ and caspase-3 at the nuclear envelope of etoposide-treated human cervical carcinoma C4-I cells.
Chiarini A; Liu D; Armato U; Dal Prà I
Int J Mol Med; 2015 Sep; 36(3):845-56. PubMed ID: 26202083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
